Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

NKCC1 Inhibitors

NKCC1 inhibitors belong to a distinctive class of chemical compounds that exhibit a unique mechanism of action within biological systems. The acronym NKCC1 stands for Sodium-Potassium-Chloride Cotransporter 1, which is a membrane protein responsible for transporting sodium, potassium, and chloride ions across cell membranes. The main function of NKCC1 is to maintain cellular homeostasis by regulating the concentration of these ions. NKCC1 inhibitors interact with this cotransporter protein, thereby modulating its activity and subsequently altering ion transport dynamics. Structurally, NKCC1 inhibitors are characterized by specific chemical features that allow them to selectively bind to the NKCC1 protein. They typically possess distinct functional groups and three-dimensional arrangements that enable them to fit into the binding sites of the protein. By doing so, these inhibitors disrupt the normal ion transport process, leading to a reduction in the movement of sodium, potassium, and chloride ions across cell membranes. This inhibition can result in significant physiological effects, as ion transport plays a crucial role in numerous cellular processes, including nerve signal transmission, muscle contraction, and osmotic balance. The modulation of NKCC1 through inhibition has garnered considerable interest in the field of cellular research, as it provides a means to investigate the intricate interplay between ion transport and cellular functions. By studying the effects of NKCC1 inhibitors, researchers gain insights into the underlying mechanisms of various physiological and pathological conditions. This class of inhibitors not only serves as valuable tools for fundamental research but also holds potential implications for a wide range of applications due to their ability to influence ion transport dynamics. Overall, NKCC1 inhibitors stand as pivotal agents in deciphering the complexities of cellular ion transport and its broader impact on biological systems.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bumetanide (Ro 10-6338)

28395-03-1sc-200727
sc-200727A
1 g
5 g
$107.00
$224.00
9
(1)

Bumetanide (Ro 10-6338) is a potent inhibitor of the Na-K-2Cl cotransporter (NKCC1), exhibiting unique binding affinity that alters ion transport dynamics. Its structural features promote specific interactions with the transporter, modulating conformational states and influencing reaction kinetics. The compound's ability to disrupt ion homeostasis provides insights into cellular mechanisms, while its distinct physicochemical properties enhance its role in studying ion channel behavior and regulatory pathways.

Furosemide

54-31-9sc-203961
50 mg
$40.00
(1)

Similar to bumetanide, furosemide is a loop diuretic that inhibits NKCCIt's prescribed for edema and hypertension.

Torsemide

56211-40-6sc-213059
10 mg
$260.00
(0)

Diuver contains torasemide, a loop diuretic akin to bumetanide and furosemide.

Amlodipine

88150-42-9sc-200195
sc-200195A
100 mg
1 g
$73.00
$163.00
2
(1)

A calcium channel blocker that indirectly impacts NKCC1 through calcium modulation.

Tolvaptan

150683-30-0sc-364638
sc-364638A
10 mg
50 mg
$122.00
$612.00
(0)

An antagonist of vasopressin receptors that indirectly influences NKCCIt manages hyponatremia in specific conditions.

Benzamil•HCl

161804-20-2sc-201070
50 mg
$195.00
1
(0)

Benzamil, with NKCC1 inhibitory effects, is researched for reducing cerebral edema, particularly in traumatic brain injury cases.

RWJ-60475

204130-08-5sc-222266
sc-222266A
5 mg
25 mg
$150.00
$650.00
(0)

Explored for its NKCC1 inhibitory activity, aiming to address conditions related to ion transport imbalance.